
Chilean competition watchdog FNE approved, with restrictions, the joint venture between América Móvil’s Claro and Liberty Latin America’s VTR, which was announced in September 2021 for an undisclosed sum.
The JV was announced in September 2021 and involves an undisclosed sum. It focuses on fixed and mobile services. One condition FNE imposed is the sale of Claro’s satellite pay-TV services.
The parties agreed to transfer ownership of the operation to a fiduciary agent until the sale of the business to a new player takes effect. FNE also accepted a suggestion by the parties to divest part of the spectrum the combined company would concentrate.
VTR and Claro offered FNE to divest 10MHz in the 3.5GHz band and 10MHz in the AWS band. The spectrum returned is expected to be auctioned by telecoms regulator Subtel, as 3.5GHz is deemed the prime band for 5G.
The parties also offered to comply with usage obligations to promote the effective and efficient use of the spectrum. FNE considered the remedies package to be effective, proportional and suitable to prevent the merger from substantially impacting competition.
According to FNE, the competitive pressure exerted by other fixed broadband players, most of which have greater technological advantage because of their larger fiber footprint, such as Telefónica/KKR, Entel and Mundo, whose local operation was recently acquired by DigitalBridge, is sufficient.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas